BR112016026510A2 - Dispositivo e formulação para tratamento tópico da dor que afeta a área vulvar do órgão genital feminino - Google Patents

Dispositivo e formulação para tratamento tópico da dor que afeta a área vulvar do órgão genital feminino

Info

Publication number
BR112016026510A2
BR112016026510A2 BR112016026510A BR112016026510A BR112016026510A2 BR 112016026510 A2 BR112016026510 A2 BR 112016026510A2 BR 112016026510 A BR112016026510 A BR 112016026510A BR 112016026510 A BR112016026510 A BR 112016026510A BR 112016026510 A2 BR112016026510 A2 BR 112016026510A2
Authority
BR
Brazil
Prior art keywords
formulation
topical treatment
female genital
vulvar area
organic
Prior art date
Application number
BR112016026510A
Other languages
English (en)
Inventor
Dimino Andre'
Pappagallo Marco
Richardson Michael
Gerstheimer Franz
Garcia Quetglas Emilio
DELFGAAUW Jacqueline
Scholz Andreas
Niel Van Johannes
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of BR112016026510A2 publication Critical patent/BR112016026510A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/14—Female reproductive, genital organs

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

DISPOSITIVO E FORMULAÇÃO PARA TRATAMENTO TÓPICO DA DOR QUE AFETA A ÁREA VULVAR DO ÓRGÃO GENITAL FEMININO. A presente invenção está relacionada ao tratamento tópico da dor que afeta a área vulvar do órgão genital feminino, uma formulação para uso no dispositivo de acordo com a invenção e um kit que compreende o dispositivo de acordo com a presente invenção. Além disso, a presente invenção está relacionada a um método de tratamento tópico da dor que afeta a área vulvar do órgão genital feminino com o método citado usando o dispositivo de acordo com a presente invenção. O dispositivo é um artigo em camadas moldado para ser colocado em uso dentro de uma roupa íntima feminina e pelo menos parcialmente em contato com a pele com a área vulvar feminina e compreende uma formulação tópica.
BR112016026510A 2014-05-15 2015-05-13 Dispositivo e formulação para tratamento tópico da dor que afeta a área vulvar do órgão genital feminino BR112016026510A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461993675P 2014-05-15 2014-05-15
PCT/EP2015/000989 WO2015172885A1 (en) 2014-05-15 2015-05-13 Device and formulation for topical treatment of pain affecting the vulvar area of the female human genital organ

Publications (1)

Publication Number Publication Date
BR112016026510A2 true BR112016026510A2 (pt) 2017-08-15

Family

ID=53189772

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016026510A BR112016026510A2 (pt) 2014-05-15 2015-05-13 Dispositivo e formulação para tratamento tópico da dor que afeta a área vulvar do órgão genital feminino

Country Status (9)

Country Link
US (1) US10765848B2 (pt)
EP (2) EP3179981A1 (pt)
JP (1) JP6514718B2 (pt)
CN (1) CN106456827B (pt)
AU (1) AU2015258472B2 (pt)
BR (1) BR112016026510A2 (pt)
CA (1) CA2948689A1 (pt)
MX (1) MX2016014913A (pt)
WO (1) WO2015172885A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020008416A2 (pt) * 2017-11-08 2020-11-17 Coloplast A/S wafer adesivo para um dispositivo de ostomia, e, aparelho de ostomia.
MX2022008143A (es) * 2020-01-03 2022-12-06 Herphoric Inc Sistema de suministro de tampon para componente holistico o medicinal farmaceutico.
WO2022036435A1 (en) * 2020-08-21 2022-02-24 Hilary Brenda Scott Underwear for dispensing therapeutic substances
JP1687318S (pt) * 2020-12-25 2021-06-07
EP4277599A1 (en) * 2021-01-14 2023-11-22 Herphoric, Inc. A delivery system for a pharmaceutical, holistic or medicinal component
USD985132S1 (en) * 2021-06-01 2023-05-02 Kobayashi Pharmaceutical Co., Ltd. Cooling patch

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3521637A (en) 1967-11-28 1970-07-28 Nelson J Waterbury Tampon or similar sanitary napkin containing vitamin a
US3902493A (en) 1974-05-13 1975-09-02 Procter & Gamble Medicated catamenial tampon
US5178139A (en) * 1990-03-05 1993-01-12 Stephen P. Angelillo Absorbent pad and thermal pack
FR2753630A1 (fr) 1996-09-20 1998-03-27 Montmarin Jean Luc De Utilisation de protections periodiques feminines, externes ou internes, comme support de traitements preventifs ou curatifs, de reactifs ou comme moyen de prelevement biologique
US6150400A (en) * 1997-06-30 2000-11-21 Presutti Laboratories Method for treating vulvar vestibulitis
WO2000069483A1 (en) 1999-05-19 2000-11-23 The Procter & Gamble Company Absorbent article with skin care composition
CA2368584A1 (en) * 1999-05-19 2000-11-23 The Procter & Gamble Company Absorbent article with skin care composition
US6355637B1 (en) * 1999-10-01 2002-03-12 Advanced Medicine, Inc. Local anesthetic compounds
US20020120242A1 (en) * 2000-12-22 2002-08-29 Tyrrell David John Absorbent articles with hydrophilic compositions containing botanicals
US6468557B1 (en) * 2001-01-05 2002-10-22 Alphamed Pharmaceutical Corp. Method for treating infectious viral diseases
SE0102152L (sv) 2001-06-18 2002-12-19 Sca Hygiene Prod Ab Ny produkt
GB2382302B (en) * 2001-11-20 2006-08-02 Susan Evelyn Anton Pharmaceutical compositions
US20030100877A1 (en) * 2001-11-27 2003-05-29 Erdman Carol L. Absorbent garment with incorporated skin wellness ingredients
US20030120225A1 (en) * 2001-12-21 2003-06-26 Kimberly-Clark Worldwide, Inc. Therapeutic agent delivery labial pad
DK1506781T3 (da) 2003-11-03 2005-06-13 Peter-Hansen Volkmann Vaginalplejesammensætning
CA2572939C (en) * 2004-07-23 2011-04-26 Stephen M. Renzin Mini pad for reducing inflammation of the vulva and method of making the same
US7592371B2 (en) * 2004-08-18 2009-09-22 Medrx Co., Ltd. External preparation
MX2007013631A (es) * 2005-05-09 2008-01-24 Drugtech Corp Composiciones farmaceuticas de liberacion modificada.
WO2008110872A2 (en) 2006-06-23 2008-09-18 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
AU2006350318A1 (en) * 2006-11-02 2008-05-08 Sca Hygiene Products Ab Delivery device
AU2006350773A1 (en) * 2006-11-17 2008-05-22 Sca Hygiene Products Ab Sanitary article comprising a microbe-inhibiting composition
MX2014013948A (es) 2012-05-25 2015-02-17 Kimberly Clark Co Articulos absorbentes de cuidado personal mejorados.
CN203724320U (zh) * 2014-01-14 2014-07-23 深圳喜安康生物科技有限公司 一种具有杀菌消炎安经止痛功能的卫生巾

Also Published As

Publication number Publication date
CN106456827B (zh) 2020-10-02
MX2016014913A (es) 2017-04-11
JP2017520518A (ja) 2017-07-27
CN106456827A (zh) 2017-02-22
US10765848B2 (en) 2020-09-08
AU2015258472A1 (en) 2016-12-22
JP6514718B2 (ja) 2019-05-15
EP3626230A1 (en) 2020-03-25
WO2015172885A1 (en) 2015-11-19
US20170056635A1 (en) 2017-03-02
CA2948689A1 (en) 2015-11-19
EP3179981A1 (en) 2017-06-21
AU2015258472B2 (en) 2020-05-21

Similar Documents

Publication Publication Date Title
BR112016026510A2 (pt) Dispositivo e formulação para tratamento tópico da dor que afeta a área vulvar do órgão genital feminino
TWD192896S (zh) 按摩器
CL2015002691A1 (es) Miostatina antagonista en sujetos humanos
UY35693A (es) Pirazolo[1,5-a]piridin-3-carboxamidas sustituidas y su uso
CL2015003801A1 (es) Formulaciones de anticuerpos y metodos
GT201600002A (es) Bencil-1h-pirazolo[3,4-b]piridinas y su uso
DOP2012000299A (es) 5-fluoro-1h-pirazolopiridinas sustituidas y su uso
BR112015029386A2 (pt) uso de eribulina e lenvatinibe como terapia de combinação para tratamento de câncer
BR112016000350A8 (pt) métodos de tratamento de lesões inflamatórias da rosácea e usos de uma composição farmacêutica
MX2023010501A (es) Profarmacos de dantroleno y metodos de su uso.
MX370958B (es) Uso de alquilamidotiazoles en preparaciones cosméticas o dermatológicas para la profilaxis y el tratamiento de piel sensible.
CO2018012180A2 (es) Métodos de tratamiento para enfermedades colestásicas y fibróticas
CO7101244A2 (es) Fenilimidazopirazoles sustituidos y su uso
BR112019012084A2 (pt) uso médico de interferon-lambda para o tratamento de fibrose
BR112016015997A2 (pt) ?composições farmacêuticas que compreendem 15- hepe e métodos para tratar asma e distúrbios pulmonares com o uso das mesmas?
BR112016029996A2 (pt) utilização cosmética, composição e método cosmético para tratar os odores corporais
BR112015024703A2 (pt) formulação farmacêutica, método de tratamento e/ou prevenção de restenose e kit para o tratamento e/ou prevenção de restenose
AR095594A1 (es) Métodos para tratar infecciones en pacientes con sobrepeso y obesos usando antibióticos
UY35610A (es) Derivados de prodroga de triazolpiridinas sustituidas
BR112016002580A2 (pt) composição para tratamento antienvelhecimento de pele
CL2015003460A1 (es) Composiciones oftálmicas acuosas tópicas que contienen un derivado de 1h-indol-1-carboxamida y uso de estas para el tratamiento de una enfermedad oftálmica
CO7151515A2 (es) Métodos para tratar deficiencia en la marcha y/o equilibrio en pacientes con esclerosis múltiple que utilizan una aminopiridina
PH12015501538A1 (en) Topical ocular analgesic agents
BR112015022275B8 (pt) Composições pigmentadas para tratamento da pele
UY37671A (es) N-ariletil-2-aminoquinolin-4-carboxamidas sustituidas y su uso

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time